David Kramer

David Kramer serves as the primary procurement lead for the Food and Drug Administration, overseeing the acquisition of advanced analytical instrumentation, laboratory automation systems, and digital diagnostic technologies critical to the agency’s scientific and regulatory mission. He manages complex contracting actions for high-precision equipment and maintenance services that support the evaluation of drug safety, medical device performance, and food safety standards. His work directly enables the FDA’s modernization efforts by ensuring laboratories and inspection units have access to cutting-edge, compliant technologies that enhance data integrity and regulatory decision-making. Kramer maintains strategic relationships with leading federal contractors including Peraton Enterprise Solutions LLC, Deloitte Consulting LLP, Booz Allen Hamilton Inc., and MPF-ZAI Solutions LLC, often engaging them for integrated technology deployment, systems integration, and specialized analytical support services. His procurement approach favors established federal contractors with proven capabilities in scientific instrumentation and compliance-driven IT environments, while maintaining rigorous oversight of contract performance and technical deliverables. These partnerships are typically structured as indefinite-delivery/indefinite-quantity (IDIQ) or cost-reimbursement contracts to accommodate evolving scientific requirements. His contracting patterns reflect a strong preference for unrestricted competition, with 94.4% of awards issued without set-aside designations, indicating a focus on technical capability over socioeconomic classification. While small business participation is limited to 5.6% of awards, primarily under Total Small Business Set-Asides, his portfolio prioritizes mission-critical performance over socioeconomic targets. Kramer’s procurement focus centers on NAICS 811210 for electronic and precision equipment repair and maintenance, and 334516 for analytical laboratory instrument manufacturing, with secondary emphasis on irradiation apparatus manufacturing under 334517. He routinely procures mass spectrometers, chromatography systems, radiation-emitting diagnostic tools, and automated sample processing platforms—technologies essential to the FDA’s scientific laboratories and field inspection units. His expertise lies in navigating the intersection of regulatory compliance, technical specifications, and lifecycle support for high-stakes scientific infrastructure.